Suppr超能文献

血浆生物标志物对肠缺血的诊断准确性。

Diagnostic accuracy of plasma biomarkers for intestinal ischaemia.

作者信息

Block T, Nilsson T K, Björck M, Acosta S

机构信息

Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden.

出版信息

Scand J Clin Lab Invest. 2008;68(3):242-8. doi: 10.1080/00365510701646264.

Abstract

OBJECTIVE

Intestinal ischaemia is a life-threatening condition with high mortality, and the lack of accurate and readily available diagnostic methods often results in delay in diagnosis and treatment. The aim of this study was to investigate the accuracy of different plasma biomarkers in diagnosing intestinal ischaemia.

MATERIAL AND METHODS

Prospective inclusion of patients older than 50 years with acute abdomen admitted to hospital in Karlskrona, Sweden, between 2001 and 2003. Venous blood was sampled prior to any surgery and within 24 h from onset of pain. D-lactate, alpha glutathione S-transferase, intestinal fatty acid binding protein, creatine kinase B, isoenzymes of lactate dehydrogenase (LD) and alkaline liver phosphatase (ALP) were analysed. D-dimer was analysed using four different commercially available test kits.

RESULTS

In-hospital mortalities among patients with (n = 10) and without (n = 61) intestinal ischaemia were 40 % and 3 %, respectively (p = 0.003). D-dimer was associated with intestinal ischaemia (p = 0.001) independently of which assay was used. No patient presenting with a normal D-dimer had intestinal ischaemia. D-dimer >0.9 mg/L had a specificity, sensitivity and accuracy of 82 %, 60 % and 79 %, respectively. Total LD, isoenzymes of LD 1-4 and liver isoenzyme of ALP (ALP liver) were significantly higher in patients with intestinal ischaemia, and accuracies for LD 2 (cut-off 2.3 microkat/L) and ALP liver (cut-off 0.7 microkat/L) were 69 % and 66 %, respectively.

CONCLUSIONS

D-dimer may be used as an exclusion test for intestinal ischaemia, but lacks specificity. The other plasma biomarkers studied had insufficient accuracy for this group of patients. Further studies are needed.

摘要

目的

肠缺血是一种危及生命的疾病,死亡率很高,且缺乏准确且易于获得的诊断方法常常导致诊断和治疗延迟。本研究的目的是调查不同血浆生物标志物在诊断肠缺血中的准确性。

材料与方法

前瞻性纳入2001年至2003年期间在瑞典卡尔斯克鲁纳住院的50岁以上急性腹痛患者。在任何手术前以及疼痛发作后24小时内采集静脉血。分析D-乳酸、α-谷胱甘肽S-转移酶、肠脂肪酸结合蛋白、肌酸激酶B、乳酸脱氢酶(LD)同工酶和碱性肝磷酸酶(ALP)。使用四种不同的市售检测试剂盒分析D-二聚体。

结果

患有(n = 10)和未患有(n = 61)肠缺血的患者的院内死亡率分别为40%和3%(p = 0.003)。无论使用哪种检测方法,D-二聚体均与肠缺血相关(p = 0.001)。D-二聚体正常的患者均无肠缺血。D-二聚体>0.9 mg/L的特异性、敏感性和准确性分别为82%、60%和79%。肠缺血患者的总LD、LD 1-4同工酶和ALP的肝同工酶(ALP肝)显著更高,LD 2(临界值2.3微卡特/升)和ALP肝(临界值0.7微卡特/升)的准确性分别为69%和66%。

结论

D-二聚体可作为肠缺血的排除试验,但缺乏特异性。所研究的其他血浆生物标志物对该组患者的准确性不足。需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验